STRS Ohio’s Pyxis Oncology PYXS Stock Holding History

STRS Ohio’s Portfolio PYXS Stock Details PYXS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,500	Closed	-$10K	–	2234
2022 Q1	$10K	Hold	2,500	–	–	﹤0.01%	2092
2021 Q4	$27K	Buy	+2,500	New	+$28.6K	﹤0.01%	2083

Other funds holding PYXS

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

STRS Ohio's PYXS Position: Q2 2022 in Review

STRS Ohio sold out of Pyxis Oncology (PYXS) in Q2 2022, closing a stake of 2,500 shares — an estimated $10K sold.

STRS Ohio first reported a position in PYXS in Q4 2021 and held it in 2 quarters. The position peaked at $27K in Q4 2021. 39 funds tracked by Wall St. Rank hold PYXS as of Q2 2022.

STRS Ohio reported no remaining Pyxis Oncology position as of Q2 2022 after selling out during the quarter.
STRS Ohio sold 2,500 Pyxis Oncology shares in Q2 2022, an estimated $10K.
STRS Ohio first reported a position in Pyxis Oncology in Q4 2021 and held it in 2 quarters.
STRS Ohio's Pyxis Oncology position peaked at $27K in Q4 2021.
39 funds tracked by Wall St. Rank held Pyxis Oncology as of Q2 2022.

Based on STRS Ohio's 13F filing for Q2 2022, filed 25 Jul 2022.